Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

We continue to collect information in support of the hypothesis that the histology of the first draining lymph node (sentinel node) accurately predicts the histology of the rest of the axillary lymph nodes.

Key facts

Study ID

NCT00575744

Run by

University of Arkansas

People needed

699

Starts

1998-12-01

Expected to finish

2011-10-01

Last updated by the study team

2016-10-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer requiring lymph node evaluation
• Clinically negative lymph nodes in the axilla
• Willing participation following an informed consent process

You may not qualify if…

• Patients with clinically positive lymph nodes
• Pregnancy (if a pregnant female should be diagnosed with breast cancer an exception would be considered on a case to case basis)
• Previous axillary lymphadenectomy

Where it is running

• University of Arkansas For Medical Sciences — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.